« Previous
Next »
American Journal of Cardiology
Volume 102, Issue 12
, Pages 1614-1617
, 15 December 2008
Impact of “Nuisance” Bleeding on Clopidogrel Compliance in Patients Undergoing Intracoronary Drug-Eluting Stent Implantation
References
- . Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502
- . Clopidogrel for the Reduction of Events During Observation (Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial). JAMA. 2002;288:2411–2420
- . Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331–337
- Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706–1717
- . Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803–2809
- . Assessment of bleeding events in clinical trials—proposal of a new classification. Am J Cardiol. 2007;99:288–290
- Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–2130
- Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113:1108–1113
- Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001–2015
PII: S0002-9149(08)01383-0
doi: 10.1016/j.amjcard.2008.07.063
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 102, Issue 12
, Pages 1614-1617
, 15 December 2008
